Cardiac diagnostics and monitoring
Clinical evidence
View clinical evidence on continuous cardiac monitoring.
The LINQ™ family of ICMs (Reveal LINQ™ ICM and LINQ II™ ICM) has been featured in 1,000+ published clinical articles and abstracts.
Read about how the CRYSTAL-AF study showed that the Reveal LINQ™ ICM is superior to standard monitoring for atrial fibrillation (AF) detection in cryptogenic stroke patients.
Review the STROKE AF study that showed that the Reveal LINQ™ ICM is superior to site-specific usual care for AF detection in large- and small-vessel stroke patients.
Learn about the clinical impact of this study, which evaluated Reveal™ ICM use in patients with unexplained syncope.
Explore the results of this study, which evaluated continuous, long-term monitoring with Reveal LINQ™ ICM for patients at high risk for AF and stroke.
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.